— Know what they know.
Not Investment Advice
Also trades as: HGENQ (OTC) · $vol 0M

HGEN NASDAQ

Humanigen, Inc.
1W: +0.0% 1M: -91.7% 3M: -95.0% 1Y: -99.9% 3Y: -100.0% 5Y: -100.0%
$0.00
Last traded 2024-01-30 — delisted
NASDAQ · Healthcare · Biotechnology

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$3M -30.1% ▼
Gross Profit
$3M -30.1% ▼
Operating Income
-$68M +70.7% ▲
Net Income
-$70M +70.6% ▲
EPS (Diluted)
$-1.18 +71.1% ▲
EBITDA
-$67M +71.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$0$0$312K$4M$3M
YoY Growth+0.0%+0.0%+0.0%+1052.2%-30.1%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$312K$4M$3M
Gross Margin——100.0%100.0%100.0%
R&D Expenses$2M$3M$73M$213M$55M
SG&A Expenses$9M$6M$16M$23M$16M
Operating Expenses$11M$9M$89M$236M$71M
Operating Income-$11M-$9M-$88M-$233M-$68M
Operating Margin——-28268.6%-6474.9%-2716.9%
Interest Expense$852K$1M$1M$2M$3M
Income Before Tax-$12M-$10M-$90M-$237M-$71M
Tax Expense$0$1M$1M$2M-$492K
Net Income-$12M-$12M-$91M-$239M-$70M
Net Margin——-29125.3%-6645.7%-2793.9%
EPS (Diluted)$-0.63$-0.52$-2.46$-4.08$-1.18
EBITDA-$11M-$9M-$88M-$234M-$67M
Shares Outstanding19M22M37M59M59M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms